Press releases
- Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
- Edwards Lifesciences to Sell Critical Care to BD
- Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe With Technology to Enhance Durability
- Edwards Lifesciences Reports First Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
- Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
More ▼
Key statistics
On Monday, Edwards Lifesciences Corp (EW*:MEX) closed at 1,623.50, -1.38% below its 52-week high of 1,646.17, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1,623.50 |
---|---|
High | 1,623.50 |
Low | 1,623.50 |
Bid | -- |
Offer | -- |
Previous close | 1,623.50 |
Average volume | 635.00 |
---|---|
Shares outstanding | 602.60m |
Free float | 597.19m |
P/E (TTM) | 39.21 |
Market cap | 54.98bn USD |
EPS (TTM) | 2.33 USD |
Data delayed at least 20 minutes, as of Jun 24 2024 12:30 BST.
More ▼